Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 28;7(22):e14286. doi: 10.14814/phy2.14286

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Effects of single or combined treatment with ipragliflozin and pioglitazone on liver histopathological scores for (a) microvesicular steatosis, (b) hepatocellular hypertrophy, (c) inflammation, and (d) fibrosis in type 2 diabetic mice with NASH. Ipragliflozin and/or pioglitazone was orally administered to diabetic mice with NASH for 4 weeks. Values indicate individual data and median for six animals per group. *p < .05 versus normal group, ^# p < .05 versus vehicle group, ^$ p < .05 versus pioglitazone (10 mg/kg) group